The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
Abstract The novel coronavirus outbreak began in late December 2019 and rapidly spread worldwide, critically impacting public health systems. A number of already approved and marketed drugs are being tested for repurposing, including Favipiravir. We aim to investigate the efficacy and safety of Favi...
Guardado en:
Autores principales: | Soheil Hassanipour, Morteza Arab-Zozani, Bahman Amani, Forough Heidarzad, Mohammad Fathalipour, Rudolph Martinez-de-Hoyo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1c848e5c102c42d3ac75d1b6a3f145a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sharing Solidarity Experiences to Overcome COVID-19
por: Morteza Arab-Zozani, et al.
Publicado: (2020) -
Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis
por: Soheil Hassanipour, et al.
Publicado: (2020) -
Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
por: Behnam Amani, et al.
Publicado: (2021) -
Survival Rate of Breast Cancer in Eastern Mediterranean Region Countries: A Systematic Review and Meta-Analysis
por: Soheil Hassanipour, et al.
Publicado: (2019) -
Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
por: Hany M. Dabbous, et al.
Publicado: (2021)